Dr. David Klimstra is a Consultant Pathologist for the Department of Pathology. Dr. Klimstra is an expert in the pathology of pancreatobiliary and gastrointestinal neoplasms and reviews cases submitted from pathologists around the world, while also providing diagnostic expertise for the MSK gastrointestinal pathology team. Dr. Klimstra served as the Chair of the Pathology Department and held the James Ewing Alumni Chair in Pathology from 2012-2021.
Find a Clinical Trial for You
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
David S. Klimstra discloses the following relationships and financial interests:
American Registry of Pathology Provision of Services
Paige.AI, Inc. Fiduciary Role/Position; Ownership / Equity Interests; Provision of Services
UptoDate Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at firstname.lastname@example.org.